A systematic review of reviews on the prevalence of anxiety disorders in adult populations.

Remes O, Brayne C, van der Linde R, Lafortune L. · 2016

Read A systematic review of reviews on the prevalence of anxiety disorders in adult populations. by Remes O, Brayne C, van der Linde R, Lafortune L. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4951626.txt.

Introduction

Olivia Remes, Carol Brayne, Rianne van der Linde, and Louise Lafortune review prior reviews on how common anxiety disorders are in adults. Their systematic review of reviews appeared in Brain and Behavior in 2016. The field was fragmented, with many small studies giving scattered rates. The team searched for systematic reviews and meta-analyses that met at least half of a standard quality checklist. They then compared prevalence across population groups and settings.

Forty-eight reviews qualified. Reported prevalence of anxiety disorders ranged from 3.8 to 25 percent overall. Rates ran higher in women, at 5.2 to 8.7 percent, and in young adults. People with chronic diseases showed the widest range of all, from 1.4 to 70 percent. Rates also differed by world region and culture. The authors flag thin coverage for indigenous groups and for much of Africa, Asia, and South America. They call for stronger primary studies in those settings.

Catalog record

CREATORRemes O, Brayne C, van der Linde R, Lafortune L.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE59 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4951626

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

A systematic review of reviews on the prevalence of anxiety disorders in adult populations By Olivia Remes, Carol Brayne, Rianne van der Linde, Louise Lafortune Published in: Brain and Behavior DOI: 10.1002/brb3.497 ABSTRACT Abstract Background A fragmented research field exists on the prevalence of anxiety disorders. Here, we present the results of a systematic review of reviews on this topic. We included the highest quality studies to inform practice and policy on this issue. Method Using PRISMA methodology, extensive electronic and manual citation searches were performed to identify relevant reviews. Screening, data extraction, and quality assessment were undertaken by two reviewers. Inclusion criteria consisted of systematic reviews or meta‐analyses on the prevalence of anxiety disorders that fulfilled at least half of the AMSTAR quality criteria. Results We identified a total of 48 reviews and described the prevalence of anxiety across population subgroups and settings, as reported by these studies. Despite the high heterogeneity of prevalence estimates across primary studies, there was emerging and compelling evidence of substantial prevalence of anxiety disorders generally (3.8–25%), and particularly in women (5.2–8.7%); young adults (2.5–9.1%); people with chronic diseases (1.4–70%); and individuals from Euro/Anglo cultures (3.8–10.4%) versus individuals from Indo/Asian (2.8%), African (4.4%), Central/Eastern European (3.2%), North African/Middle Eastern (4.9%), and Ibero/Latin cultures (6.2%). Conclusions The prevalence of anxiety disorders is high in population subgroups across the globe. Recent research has expanded its focus to Asian countries, an increasingly greater number of physical and psychiatric conditions, and traumatic events associated with anxiety. Further research on illness trajectories and anxiety levels pre‐ and post‐treatment is needed. Few studies have been conducted in developing and under‐developed parts of the world and have little representation in the global literature. Keywords: Anxiety, anxiety disorders, demographics, epidemiology, international, mental disorders, prevalence INTRODUCTION Anxiety disorders – defined by excess worry, hyperarousal, and fear that is counterproductive and debilitating – are some of the most common psychiatric conditions in the Western world (Simpson et al. 2010). The prevalence of anxiety disorders in the United States is estimated to be 18% (Kessler et al. 2005), and their annual cost is reported to be $42.3 billion (Greenberg et al. 1999). In the European Union (EU), over 60 million people are affected by anxiety disorders in a given year, making them the most prevalent psychiatric conditions in the EU (Wittchen et al. 2011). The Global Burden of Disease (GBD) study estimated that anxiety disorders contributed to 26.8 million disability adjusted life years in 2010. (Whiteford et al. 2013). While a number of reviews have focused on the burden of depression and its economic, social, and health care policy implications, substantially fewer have assessed anxiety. The past decade has seen increased research interest into anxiety disorders, in large part because of a greater recognition of their burden and the implications associated with untreated illness. Clinical reviews have shown that the presence of an anxiety disorder is a risk factor for the development of other anxiety and mood disorders and substance abuse. In clinical and population‐based studies, the development of comorbidities makes the treatment of primary and secondary disorders difficult, contributes to low remission rates, poor prognosis and risk of suicide (Nutt and Ballenger 2003; Simpson et al. 2010). Untreated anxiety has been associated with significant personal and societal costs, related to frequent primary and acute care visits, decreased work productivity, unemployment, and impaired social relationships (Simpson et al. 2010). A number of primary studies on the prevalence of anxiety have been undertaken, but the variability in findings has made generalizability to the wider population difficult. This variability mainly results from differences in study setting (i.e., culture; clinical vs. population‐based), age and sex composition of samples, length of follow‐up, methods of anxiety assessment, and caseness criteria (i.e., types and number of disorders examined). Systematic reviews on the prevalence of these conditions in highly select, homogeneous population subgroups have been undertaken, but the selective citation of such estimates presents a distorted view of the overall burden of anxiety and limits generalizability. The aim of this systematic review of reviews was to provide a comprehensive synthesis and description of the prevalence of anxiety disorders in the general population, as well as in clinical outpatient and inpatient groups affected by a range of chronic physical diseases and psychiatric disorders, as reported by individual reviews. Individuals recruited from the community can have different risk factor profiles than those sampled from clinical settings, potentially giving rise to different rates of mental health problems amongst these groups (Nutt and Ballenger 2003; Simpson et al. 2010). As a result, the burden needs to be assessed across different settings and segments of the population. To provide insight into the demographic groups that are most affected, we reported on estimates for men and women and different age groups, if this information was available. Since a number of studies (Walters et al. 2004; Skapinakis et al. 2005; Simpson et al. 2010) have identified the need to better understand the geographical variation of mental health problems, we included reviews that captured studies conducted across the globe at national and subnational levels. To provide insight into the chronicity of anxiety disorders, we provided period (i.e., 12‐month) and lifetime prevalence estimates. If the duration criterion was not clearly stated or the “point” or “current” prevalence was indicated, we simply referred to these estimates as “prevalence”. Findings from this systematic review will shed light on the groups that are most affected by anxiety disorders, and can be used to inform targeted screening and treatment efforts. This will be important in the planning of health services and the development of evidence‐based policy. Finally, results from this review can be used to identify areas where further research is needed. This is the first study to provide a comprehensive synthesis of the disparate findings from systematic reviews undertaken on the burden of anxiety across the globe and using a systematic approach. METHODS Search strategy We defined a systematic review in accordance with the Cochrane Collaboration and the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) Statement (Moher et al. 2009). (Appendix 1) We included high‐quality reviews that reported the prevalence of anxiety disorders in the general population or clinic‐based settings. We searched for reviews on young, middle‐aged, and older adults with risk behaviors (i.e., drug abuse), chronic or infectious diseases, psychiatric conditions, who are vulnerable, and living in countries across the globe. Reviews on the treatment of anxiety were not included, as we consider this to be a separate review topic that would merit an in‐depth analysis. To identify reviews meeting the inclusion criteria, we searched Medline (inception‐May, 2015), PsycInfo (1987‐May, 2015), and Embase (inception‐May, 2015) using combinations of keywords relating to anxiety and prevalence (Appendix 2). Reference lists were hand‐searched for additional reviews. Titles and abstracts of non‐English language articles were translated to assess relevance. We excluded unpublished data. The review protocol is registered on PROSPERO (Remes et al. 2014). Inclusion criteria We searched for reviews that reported the lifetime, period, or point prevalence (or simply “prevalence”) of generalized anxiety disorder (GAD), obsessive‐compulsive disorder (OCD), social anxiety disorder (SAD) or social phobia, agoraphobia, panic disorder (PD) with or without agoraphobia, and simple or specific phobia, and anxiety not otherwise specified (NOS).

Read the complete text